Molecular Analysis of the PfEMP1 Binding Activity
PfEMP1 结合活性的分子分析
基本信息
- 批准号:8373886
- 负责人:
- 金额:$ 46.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffinityAntibodiesBindingBiologicalBiological AssayCD36 geneCarrier ProteinsCell surfaceChondroitin Sulfate ACleaved cellComplexCytoplasmEngineeringErythrocyte MembraneErythrocytesExclusionFamilyGoalsGrantHumanIn VitroInfectionInterventionLinkMalariaMapsMass Spectrum AnalysisMediatingMembraneMembrane ProteinsMolecularMolecular AnalysisMutagenesisN-terminalOrganOrganellesParasitesPathogenesisPathway interactionsPharmaceutical PreparationsPlacentaPlasmodiumPlasmodium falciparumProcessPropertyProtein BindingProtein Export PathwayProteinsRecombinant ProteinsRoleSeverity of illnessSignal TransductionSiteSite-Directed MutagenesisSpleenStagingSurfaceTransgenesTransgenic OrganismsUnited States National Institutes of HealthVaccinesVacuoleVariantVirulenceWorkbasedesignhuman diseasein vivonew therapeutic targetnovelparasite genomepressurepreventprotein functionprotein transportreceptortherapy developmentthree dimensional structuretrafficking
项目摘要
DESCRIPTION (provided by applicant): Plasmodium falciparum infected erythrocytes (IEs) persist in the host and avoid clearance in the spleen by varying expression of a family of cytoadhesion proteins at the IE surface called P. falciparum erythrocyte membrane protein 1 (PfEMP1). Different PfEMP1s bind to different host receptors and thereby target IEs to sequester in the microvasculature of different organs, which in turn determines disease severity. PfEMP1 surface transport is a multi-step process that involves protein export across the parasitophorus vacuole membrane (PVM) (early transport) and protein transfer through the erythrocyte cytoplasm (via Maurer's cleft organelles) to the IE surface (late transport). Each parasite genome encodes ~60 PfEMP1 proteins that are expressed in a mutually exclusion fashion. Most proteins bind to the host receptor CD36, except for an unusually conserved PfEMP1 variant that mediates infected erythrocyte sequestration in the placenta. This project is designed to elucidate important determinants in PfEMP1 transport and assembly at the IE surface and define how PfEMP1 proteins have evolved to maintain key binding interactions despite intense antibody pressure. A combination of in vitro and in vivo assays employing heterologous recombinant proteins and parasite lines expressing transgenic miniPfEMP1 proteins will be used to define accessory proteins involved in PfEMP1 transport and function and to map critical interaction residues in cytoadhesion. These studies will contribute to a detail characterization of the cytoadhesive properties of P. falciparum infected erythrocytes and enable a greater understanding of the molecular basis of malaria pathogenesis.
描述(由申请方提供):恶性疟原虫感染的红细胞(IE)在宿主体内持续存在,并通过改变IE表面称为恶性疟原虫红细胞膜蛋白1(PfEMP 1)的细胞粘附蛋白家族的表达来避免在脾脏中清除。不同的PfEMP1结合不同的宿主受体,从而靶向IE以隔离不同器官的微血管系统,这反过来又决定了疾病的严重程度。PfEMP 1表面转运是一个多步骤的过程,涉及蛋白质跨寄生虫空泡膜(PVM)(早期转运)和蛋白质通过红细胞质(通过Maurer's裂隙细胞器)转移到IE表面(晚期转运)。每种寄生虫基因组编码约60种PfEMP1蛋白,这些蛋白以相互排斥的方式表达。大多数蛋白质与宿主受体CD36结合,除了一种异常保守的PfEMP 1变体,它介导胎盘中受感染的红细胞隔离。该项目旨在阐明PfEMP1在IE表面转运和组装的重要决定因素,并定义PfEMP1蛋白如何进化以维持关键的结合相互作用,尽管强烈的抗体压力。采用异源重组蛋白和表达转基因miniPfEMP1蛋白的寄生虫系的体外和体内测定的组合将用于定义参与PfEMP1转运和功能的辅助蛋白,并绘制细胞粘附中的关键相互作用残基。这些研究将有助于详细描述恶性疟原虫感染红细胞的细胞粘附特性,并使人们能够更好地了解疟疾发病机制的分子基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH D SMITH其他文献
JOSEPH D SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH D SMITH', 18)}}的其他基金
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10466868 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10116030 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10269051 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
10454338 - 财政年份:2019
- 资助金额:
$ 46.85万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
10216994 - 财政年份:2019
- 资助金额:
$ 46.85万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
9817075 - 财政年份:2019
- 资助金额:
$ 46.85万 - 项目类别:
3D human-based microvessel bed for the study of Plasmodium falciparum interacting with vessel wall
用于研究恶性疟原虫与血管壁相互作用的 3D 人体微血管床
- 批准号:
9015016 - 财政年份:2015
- 资助金额:
$ 46.85万 - 项目类别:
Binding Mechanisms in P.falciparum Cerebral Malaria
恶性疟原虫脑型疟疾的结合机制
- 批准号:
8712760 - 财政年份:2013
- 资助金额:
$ 46.85万 - 项目类别:
Immunogen Design to enhance the efficacy of Plasmodium vivax vaccine
增强间日疟原虫疫苗功效的免疫原设计
- 批准号:
8050581 - 财政年份:2010
- 资助金额:
$ 46.85万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 46.85万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 46.85万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 46.85万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 46.85万 - 项目类别: